Novakand Pharma AB (publ)

    Novakand Pharma AB (publ)

    SSTO:NOVKAN
    - -
    SEK
    - -
    - -
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    0.34
    0.04
    0.02
    0.02
    0.01
    0.02
    0.13
    0.12
    0.03
    0.01
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    -1.41
    -1.2
    -1.31
    -1.35
    -3.03
    -2.06
    -1.5
    -0.93
    -0.8
    -0.88
    -0.81
    -0.39
    -0.39
    -0.39
    Free Cash Flow per Basic Share
    -1.64
    -1.48
    -1.41
    -1.4
    -2.88
    -2.02
    -1.38
    -0.9
    -0.77
    -0.8
    -0.7
    -0.51
    -0.25
    -0.25
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.9
    -0.53
    -1.71
    -2.73
    -2.3
    -1.35
    -0.77
    -5.14
    -4.57
    -4.95
    -4.5
    -3.45
    -3.66
    -3.66
    Tangible Book Value per Share
    2.46
    1.6
    1.07
    3.23
    1.12
    0.69
    -0.27
    1.18
    1.77
    1.44
    0.37
    0.38
    0.12
    0.12
    Basic Weighted Avg Shares
    5
    13
    15
    17
    19
    22
    24
    43
    57
    60
    80
    115
    121
    121
    Sales/Revenue/Turnover
    2
    - -
    - -
    - -
    - -
    - -
    3
    5
    2
    1
    - -
    - -
    - -
    - -
    Operating Margin (%)
    -573.86
    -3,424.47
    -6,980.85
    -7,234.42
    -49,684.07
    -12,976.26
    -1,116.57
    -732.72
    -2,655.87
    -6,896.95
    - -
    - -
    - -
    - -
    Depreciation Expense
    1
    1
    1
    1
    1
    1
    - -
    2
    - -
    - -
    3
    - -
    - -
    - -
    Net Income, GAAP
    -7
    -16
    -20
    -22
    -56
    -46
    -36
    -40
    -46
    -52
    -65
    -45
    -47
    -47
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -409.16
    -3,399.79
    -6,954.61
    -7,242.86
    -49,732.74
    -12,831.01
    -1,122.36
    -752.09
    -2,681.1
    -6,969.99
    - -
    - -
    - -
    - -
    Working Capital
    10
    19
    14
    54
    23
    16
    -11
    51
    102
    86
    30
    44
    15
    15
    LT Debt
    2
    2
    2
    3
    3
    1
    1
    1
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    19
    27
    22
    60
    39
    33
    17
    72
    123
    107
    48
    62
    15
    15
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    SEK

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    121
    121
    121
    Market Capitalization
    219
    34
    19

    Working Capital

    SEK

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    29
    23
    17
    Cash, Cash Equivalents & STI
    28
    22
    16
    Accounts Receivable, Net
    1
    1
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    4
    3
    2
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    SEK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    34.61%
    -8.75%
    -75.82%
    Free Cash Flow
    11.17%
    -1.02%
    -48.25%
    Net Income, GAAP
    16.42%
    5.2%
    5.98%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.22
    -0.23
    -0.13
    -0.23
    -0.81
    2024
    -0.13
    -0.09
    -0.09
    -0.08
    -0.39
    2025
    -0.11
    -0.05
    -0.19
    -0.04
    -0.39

    Quarterly Dividends Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business